D'Amour Center for Cancer Care — Springfield, Massachusetts

D'Amour Center for Cancer Care is a clinical research site located in Springfield, Massachusetts, United States 01107.

Crixeo Clinical Trials Trust Score: 16/100 (FAILING). This profile has not yet been claimed by the site owner.

D'Amour Center for Cancer Care has participated in 6 clinical trials with 2 currently active.

Therapeutic areas: Stage I Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia, Stage III Chronic Lymphocytic Leukemia.

Sponsors: National Cancer Institute (NCI), Radiation Therapy Oncology Group, Alliance for Clinical Trials in Oncology.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Springfield

Browse all research sites in Massachusetts · View every site in Springfield

Sponsor Feasibility Report

Trust Score: 16/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for D'Amour Center for Cancer Care?

D'Amour Center for Cancer Care has a Crixeo Trust Score of 16/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has D'Amour Center for Cancer Care conducted?

D'Amour Center for Cancer Care has 6 clinical trials on record, with 2 currently active. Their work covers Stage I Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia, Stage III Chronic Lymphocytic Leukemia.

Is D'Amour Center for Cancer Care accredited by Crixeo Clinical Trials?

D'Amour Center for Cancer Care has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about D'Amour Center for Cancer Care?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.